Synthesis of 6,19-sulfamidate bridged pregnanes

Journal of Organic Chemistry

Volumn 70, Issue 21, 2005, Pages 8613-8616

  Duran, Fernando J ^a   Ghini, Alberto A ^a   Dauban, Philippe ^b   Dodd, Robert H ^b   Burton, Gerardo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; CONFORMATIONS; RING OPENING POLYMERIZATION; STEREOCHEMISTRY; SUBSTITUTION REACTIONS; SULFUR COMPOUNDS;

6,9-SULFAMIDATE BRIDGED PREGNANES; NITRENE; NUCLEOPHILIC RING OPENING; REGIOSELECTIVITY;

AROMATIC COMPOUNDS;

4 AMINOBUTYRIC ACID A RECEPTOR; ACETIC ACID; AZIRIDINE DERIVATIVE; CYANIDE; FLUORIDE; NEUROSTEROID; PREGNANE DERIVATIVE; SULFANILAMIDE;

ANTICONVULSANT ACTIVITY; ARTICLE; CHEMICAL REACTION; CONFORMATIONAL TRANSITION; DERIVATIZATION; MOLECULAR INTERACTION; REACTION ANALYSIS; RING OPENING; SOLUBILITY; SYNTHESIS;

BRIDGED COMPOUNDS; MOLECULAR STRUCTURE; PREGNANES; SULFONIC ACIDS;

EID: 26844505734     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo051290a     Document Type: Article

References (29)

1. Neurosteroid Effects in the Central Nervous System: The Role of the GABA-A Receptor; Smith, S. S., Ed.; CRC Press: Boca Raton, 2003.
2. Mok, W. M.; Herschkowitz, S.; Krieger, N. R. J. Neurochem. 1991, 57, 1296-1301.
3. Mendelson, W. B.; Martin, J. V.; Perlis, M.; Wagner, R.; Majewska, M. D.; Paul, S. M. Psychopharmacology 1987, 93, 226-229.
4. (a) Bitran, D.; Hilvers, R. J.; Kellogg, C. K. Brain Res. 1991, 561, 157-161.
5. (b) Brot, M. D.; Akwa, Y.; Purdy, R. H.; Koob, G. F.; Britton, K. T. Eur. J. Pharmacol. 1997, 325, 1-7.
6. (c) Rodgers, R. J.; Johnson, N. J. T. Pharmacol. Biochem. Behav. 1998, 59, 221-232.
7. (a) Belelli, D.; Bolger, M. B.; Gee, K. W. Eur. J. Pharmacol. 1989, 166, 325-329.
8. (b) Kokate, T. G.; Svensson, B. J.; Rogawski, M. A. J. Pharmacol. Exp. Ther. 1994, 270, 1223-1229.
9. (c) Veleiro, A. S.; Rosenstein, R. E.; Jaliffa, C. O.; Grilli, M. L.; Speroni, F.; Burton, G. Bioorg. Med. Chem. Lett. 2003, 13, 343-346.
10. Anderson, A.; Boyd, A. C.; Campbell, A. C.; Gemmel, D. K.; Hamilton, N. M.; Hill, D. R.; Hill-Yenning, C.; Lambert, J. J.; Maidment, M. S.; May, V.; Marshall, R. J.; Peters, J. A.; Rees, D. C.; Stevenson D. J. Med. Chem. 1997, 40, 1668-1681.
11. Skoda-Foldes, R.; Kollar, L. Chem. Rev. 2003, 103, 4095-4129.
12. Burton, G.; Galigniana, M. D.; de Lavallaz, S.; Brachet-Cota, A. L.; Sproviero, E. M.; Ghini, A. A.; Lantos, C. P.; Damasco, M. C. Mol. Pharmacol, 1995, 47, 535-543.
13. See for example: CNS Neurotransmitters and Neuromodulators. Neuroactive Steroids; Stone, T. W., Ed.; CRC Press: Boca Raton, 1996; Chapters 2 and 4.
14. Di Chenna, P. H.; Dauban, P.; Ghini, A. A.; Baggio, R.; Garland, M. T.; Burton, G.; Dodd, R. H. Tetrahedron 2003, 59, 1009-1014.
15. (a) Han, M.; Zorumski, C. F.; Covey, D. F. J. Med. Chem. 1996, 39, 4218-4232.
16. (b) Zeng, C.-M.; Benz, A.; Howell, M.; Manion, B.; Evers, A. S.; Zorumski, C. F.; Mennerick, S.; Covey, D. F. Abstracts of Papers, 222nd National Meeting of the American Chemical Society, Chicago, IL, August 26-30, 2001; American Chemical Society: Washington, DC, 2001.
17. Nicoletti, D.; Ghini, A. A.; Furtmüller, R.; Sieghart, W.; Dodd, R. H.; Burton, G. Steroids 2000, 65, 349-356.
18. Kasal, A.; Matyas, L.; Budesinsky, M. Tetrahedron 2005, 61, 2269-2278.
19. Durán, F. J.; Leman, L.; Ghini, A. A.; Burton, G.; Dauban, P.; Dodd, R. H. Org. Lett. 2002, 4, 2481-2483.
20. Joselevich, M.; Ghini, A. A.; Burton, G. Org. Biomol. Chem. 2003, 1, 939-943.
21. Eduardo, S. L.; Ghini, A. A.; Burton, G. ARKIVOC 2003, Part X, 468-476.
22. (a) Appel, B.; Berger, G. Chem. Ber. 1958, 91, 1339-1341.
23. (b) Okada, M.; Iwashita, S.; Koizumi, N. Tetrahedron Lett. 2000, 41, 7047-7051.
24. Dauban, P.; Sanière, L.; Tarrade, A.; Dodd, R. H. J. Am. Chem. Soc. 2001, 123, 7707-7708.
25. Compound 5 decomposed on silica gel; it was purified by flash chromatography on Florisil.
26. Gee, K. W.; Bolger, M. B.; Brinton, R. E.; Coirini, H.; McEwen, B. S. J. Pharmacol. Exp. Ther. 1988, 246, 803-812.
27. The regiochemistry of the opening of conformationally rigid unsymmetrical epoxides and other three-membered heterocycles follows the Fürst-Plattner rule with exclusive formation of the diaxial product under kinetically controlled conditions. See for example: (a) Valls, J.; Toromanoff, E. Bull. Soc. Chim. Fr. 1961, 758-764.
28. (b) Deslongchamps, P. Stereoelectronic Effects in Organic Chemistry; Pergamon Press: Oxford, 1983; pp 165-166.
29. AM1 calculations show that 13 is more stable than 12 by ca. 7.8 kcal/mol (see Supporting Information).